Publications
73
Citations
775
Est. group size
—
Recurring co-author estimate
Active years
42
Publishing since 1985
Russell F. Palm is a radiation oncology researcher focused on treating gastrointestinal cancers, including pancreatic, hepatocellular (liver), rectal, and esophageal cancers, as well as soft-tissue sarcoma. His work spans clinical trials and outcome studies on radiotherapy techniques, chemotherapy combinations, immunotherapy, and emerging tools like AI-assisted decision-making and imaging-based response assessment. A prospective student would likely engage with multi-institutional clinical research examining how to personalize and improve cancer treatment through advanced radiation and multidisciplinary care strategies.
Publication output grew substantially from 2019 through a peak in 2023-2024, followed by a decline in the most recent years (2025-2026), which may reflect incomplete indexing of very recent work.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Reevaluating complete response: Assessing whether imaging alone is sufficient to predict survival after transarterial radioembolization in hepatocellular carcinoma.
Journal of Clinical Oncology · 2026
- Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis
JNCI Journal of the National Cancer Institute · 2026
- Intricacies of human–AI interaction in dynamic decision-making for precision oncology
Nature Communications · 2025
- Immune Checkpoint Inhibitor Use in Advanced Hepatocellular Carcinoma: A Real-World Analysis of Efficacy and Toxicity
Cancers · 2025
- Correlation of mid-chemoradiation ctDNA results and clinical complete response to total neoadjuvant therapy (TNT) for locally advanced rectal adenocarcinoma.
Journal of Clinical Oncology · 2025
- Personalizing Patient Education for Pancreatic Cancer Patients Receiving Multidisciplinary Care with Integration of Novel Digital Tools
Healthcare · 2025
- The Role of MRI in Breast Cancer and Breast Conservation Therapy
Cancers · 2024
- Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma
Radiotherapy and Oncology · 2024
- Novel Definitive Hypofractionated Accelerated Radiation Dose-painting (HARD) for Unresected Soft Tissue Sarcomas
Advances in Radiation Oncology · 2024
- HSR24-141: Personalizing the Patient Experience: Understanding the Emotional State and Learning Preferences of Pancreatic Cancer Patients Receiving Multidisciplinary Care
Journal of the National Comprehensive Cancer Network · 2024
- Totally minimally invasive laparoscopic robot-assisted Ivor Lewis esophagectomy: improved technique and outcomes over 200 cases
Journal of Gastrointestinal Oncology · 2024
- CT-Based Adaptive Short Course Radiotherapy for Rectal Cancer: A Case Report
Cureus · 2024
- Radiation Oncology Provider Perceptions and Attitudes Towards Virtual Tumor Boards: Is Quality Maintained and Does Virtual Format Improve Work-Life Balance?
International Journal of Radiation Oncology*Biology*Physics · 2024
- The effect of germline DNA repair mutations on radiosensitivity in pancreatic ductal adenocarcinoma.
Journal of Clinical Oncology · 2024
- Intricacies of Human-AI Interaction in Dynamic Decision-Making for Precision Oncology: A Case Study in Response-Adaptive Radiotherapy
medRxiv · 2024
- International Journal of Radiation Oncology*Biology*Physics×18
- Journal of Clinical Oncology×7
- Cancers×4
- Applied Radiation Oncology×4
- Annals of Surgical Oncology×3
- Temel Tirkes
Medicine · Indiana University
- Patrick L. Quinn
Medicine · The Ohio State University
- Niranjan Awasthi
Medicine · Indiana University
- Mark Bloomston
Medicine · The Ohio State University
- Zarine K. Shah
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile